top of page

C3-Funded Molecular Testing Program Ending December 31st, 2025
*All test requisition forms must be submitted by this date.
**Click here for more details and next steps for physicians.
***Click here for more details for patients and caregivers.

Women Holding Hands

We are the Canadian Cholangiocarcinoma Collaborative (C3)

Where hope grows and Research is Care
The C3 was founded to change how patients with cholangiocarcinoma receive and access integrated research and care in Canada. 
  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page